ECO Animal Health Group plc (LON:EAH - Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 76.78 ($1.02) and traded as high as GBX 99.85 ($1.33). ECO Animal Health Group shares last traded at GBX 99.85 ($1.33), with a volume of 153,228 shares.
Wall Street Analyst Weigh In
Separately, Shore Capital reissued a "buy" rating and set a GBX 150 price target on shares of ECO Animal Health Group in a report on Monday, July 14th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat.com, ECO Animal Health Group has an average rating of "Buy" and an average target price of GBX 150.
View Our Latest Stock Report on ECO Animal Health Group
ECO Animal Health Group Price Performance
The stock has a fifty day simple moving average of GBX 76.78 and a two-hundred day simple moving average of GBX 65.69. The company has a market cap of £66.30 million, a PE ratio of 4,042.80 and a beta of -0.05. The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.81.
ECO Animal Health Group (LON:EAH - Get Free Report) last announced its quarterly earnings data on Monday, July 14th. The company reported GBX 2.49 earnings per share for the quarter. ECO Animal Health Group had a return on equity of 1.27% and a net margin of 1.17%.
Insiders Place Their Bets
In other ECO Animal Health Group news, insider David Hallas acquired 29,897 shares of the stock in a transaction on Tuesday, July 15th. The shares were bought at an average price of GBX 67 per share, with a total value of £20,030.99. Corporate insiders own 11.03% of the company's stock.
About ECO Animal Health Group
(
Get Free Report)
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ECO Animal Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ECO Animal Health Group wasn't on the list.
While ECO Animal Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
